Oh, $@%!: Drug-resistant Shigella

Overview

Health officials around the world are sounding the alarm on a highly infectious bacteria causing extensively drug-resistant infections. Shigella, which causes the infection known as shigellosis, is a genus of bacteria that results in gastrointestinal distress that ranges from uncomfortable to deadly, in adults and children. Global surveillance efforts on Shigella have identified outbreaks of strains that are extensively drug-resistant across the UK, US, and parts of Europe. How is the world dealing with this new superbug?

Guests

• Lou Bourgeois, PhD: Johns Hopkins, Science Officer for Enteric and Diarrheal Diseases, PATH
• Gauri Godbole, MBBS, MD: UKHSA, Consultant Microbiologist and Parasitologist, Hospital for Tropical Diseases, University College London Hospitals, NHS
• Naemah Logan, MD: Medical Officer, Surveillance Epidemiologist, National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), Centers for Disease Control and Prevention (CDC)
• Louise Francois Watkins, MD: Medical Officer, NARMS, Centers for Disease Control and Prevention: CDC

Resources

• PATH Blog: Shigella: A Survivor’s Story
• Stop the Cycle: A State of the Field Report by PATH’s Defeat Diarrheal Disease Initiative (DefeatDD): Vaccines against Shigella and ETEC
• PATH Video: The protective power of vaccines against diarrhea 
• CDC Health Advisory Antimicrobial Resistance and Shigella Infections
• UK Government Press Release: Warning after rise in extremely drug-resistant Shigella - GOV.UK
•  
•